Small-molecule natural products: New structures, new activities

Current Opinion in Biotechnology

Volumn 15, Issue 6, 2004, Pages 576-583

  Baker, Dwight D ^a   Alvi, Khisal A ^b  

^a CUBIST PHARMACEUTICALS INC   (United States)

^b ALBANY MOLECULAR RESEARCH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVE SMALL MOLECULES; DRUG DISCOVERY; NATURAL PRODUCTS;

BIODIVERSITY; DRUG PRODUCTS; MICROORGANISMS; PLANTS (BOTANY);

BIOTECHNOLOGY;

ALKALOID; ALKALOID DERIVATIVE; AMPHIDINOLIDE X; AMPHIDINOLIDE Y; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILEUKEMIC AGENT; ANTIMETABOLITE; BETAINE DERIVATIVE; CRIBROSTATIN; CYTOTOXIC AGENT; DITERPENE; DYSIBETAINE CPA; DYSIBETAINE CPB; DYSIBETAINE PP; EPIBATIDINE; EPIQUINAMIDE; FR 225659; FR 235222; INDOLIZIDINE ALKALOID; KALLOSIN; KOTTAMIDE A; KOTTAMIDE B; KOTTAMIDE C; KOTTAMIDE D; PEROPHORAMIDINE; PUMILIOTOXIN; QUINOLIZIDINE DERIVATIVE; SEBASTIANINE A; SEBASTIANINE B; SF 2809 I; SF 2809 II; SF 2809 III; SF 2809 IV; SF 2809 V; SF 2809 VI; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACTINOBACTERIA; AMPHIBIA; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; DRUG ACTIVITY; DRUG ISOLATION; DRUG POTENCY; DRUG RESEARCH; DRUG STRUCTURE; FUNGAL STRAIN; GLUCONEOGENESIS; GLYCOGENOLYSIS; IC 50; MARINE ENVIRONMENT; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; REVIEW;

ACTINOBACTERIA; ANIMALS; ANURA; DRUG DESIGN; FUNGI; MYXOCOCCALES; PLANTS; UROCHORDATA;

ANIMALIA;

EID: 9244243061     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2004.09.003     Document Type: Review

References (43)

1. D.R. Appleton, M.J. Page, G. Lambert, M.V. Berridge, and B.R. Copp Kottamides A-D: novel bioactive imidazolone-containing alkaloids from the New Zealand ascidian Pycnoclavella kottae J Org Chem 67 2002 5402 5404
2. S.M. Verbitski, C.L. Mayne, R.A. Davis, G.P. Concepcion, and C.M. Ireland Isolation, structure determination, and biological activity of a novel alkaloid, perophoramidine, from the Philippine ascidian Perophora namei J Org Chem 67 2002 7124 7126
3. Y.R. Torres, T.S. Bugni, R.G. Berlinck, C.M. Ireland, A. Magalhaes, A.G. Ferreira, and D.R. Moreira Sebastianines A and B, novel biologically active pyridoacridine alkaloids from the Brazilian ascidian Cystodytes dellechiajei J Org Chem 67 2002 5429 5432 The compounds reported in this article and by Verbitski et al. [2] belong to a class of alkaloids that contain the pyridoacridine alkaloid skeleton - perhaps the fastest growing class of ascidian metabolites. These compounds, in addition to providing a challenge to natural product chemists, often exhibit an array of biological activities.
4. J. Marrero, A.D. Rodriguez, P. Baran, and R.G. Raptis Isolation and characterization of kallosin A, a novel rearranged pseudopterane diterpenoid from the Caribbean sea plume Pseudopterogorgia kallos (Bielschowsky) J Org Chem 68 2003 4977 4979
5. M. Tsuda, N. Izui, K. Shimbo, M. Sato, E. Fukushi, J. Kawabata, K. Katsumata, T. Horiguchi, and J. Kobayashi Amphidinolide X, a novel 16-membered macrodiolide from dinoflagellate Amphidinium sp J Org Chem 68 2003 5339 5345
6. K. Shimbo, M. Tsuda, N. Izui, and J. Kobayashi Amphidinolide W, a new 12-membered macrolide from dinoflagellate Amphidinium sp J Org Chem 67 2002 1020 1023
7. M. Tsuda, N. Izui, K. Shimbo, M. Sato, E. Fukushi, J. Kawabata, and J. Kobayashi Amphidinolide Y, a novel 17-membered macrolide from dinoflagellate Amphidinium sp.: plausible biogenetic precursor of amphidinolide X J Org Chem 68 2003 9109 9112
8. J. Kobayashi, and M. Tsuda Amphidinolides, bioactive macrolides from symbiotic marine dinoflagellates Nat Prod Rep 21 2004 77 93 A comprehensive review of the secondary metabolites from this symbiotic marine unicellular alga from the research group that has contributed most to its chemistry.
9. R. Sakai, K. Suzuki, K. Shimamoto, and H. Kamiya Novel betaines from a micronesian sponge Dysidea herbacea J Org Chem 69 2004 1180 1185
10. Goetz GH, Harrigan GG, Likos JJ, Kasten TP: Protease inhibitors of the coagulation cascade isolated from Dysidea sponges. 2003 US Patent PCT/US02/200001[WO 03/051831 A2].
11. Pettit GR, Knight JC: Cribrostatins 3-5. 2002 US Patent 09/785854[US 6437128 B1].
12. Y. Sakano, M. Shibuya, A. Matsumoto, Y. Takahashi, H. Tomoda, S. Omura, and Y. Ebizuka Lanopylins A1, B1, A2 and B2, novel lanosterol synthase inhibitors from Streptomyces sp. K99-5041 J Antibiot (Tokyo) 56 2003 817 826 It is interesting to note that lanopylins are the first natural product inhibitors of lanosterol synthase and their potency was comparable to the known oxidosqualene cyclase inhibitors, lauryl dimethylamine-N-oxide (LDAO) and AMO1618.
13. M. Tani, K. Harimaya, Y. Gyobu, T. Sasaki, O. Takenouchi, T. Kawamura, T. Kamimura, and T. Harada SF2809 compounds, novel chymase inhibitors from Dactylosporangium sp. 2. Structural elucidation J Antibiot (Tokyo) 57 2004 89 96
14. M. Tani, Y. Gyobu, T. Sasaki, O. Takenouchi, T. Kawamura, T. Kamimura, and T. Harada SF2809 compounds, novel chymase inhibitors from Dactylosporangium sp. 1. Taxonomy, fermentation, isolation and biological properties J Antibiot (Tokyo) 57 2004 83 88
15. M.P. Singh, P.J. Petersen, W.J. Weiss, J.E. Janso, S.W. Luckman, E.B. Lenoy, P.A. Bradford, R.T. Testa, and M. Greenstein Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities Antimicrob Agents Chemother 47 2003 62 69 This paper and the article from Ruzin et al. [16], provide an interesting description of the chemical characterization of a bioactive antibiotic complex almost 30 years after it was patented.
16. A. Ruzin, G. Singh, A. Severin, Y. Yang, R.G. Dushin, A.G. Sutherland, A. Minnick, M. Greenstein, M.K. May, D.M. Shlaes, and P.A. Bradford Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant Gram-positive bacteria Antimicrob Agents Chemother 48 2004 728 738
17. H.B. Bode, H. Irschik, S.C. Wenzel, H. Reichenbach, R. Muller, and G. Hofle The leupyrrins: a structurally unique family of secondary metabolites from the myxobacterium Sorangium cellulosum J Nat Prod 66 2003 1203 1206
18. F. Sasse, T. Leibold, B. Kunze, G. Hofle, and H. Reichenbach Cyrmenins, new β-methoxyacrylate inhibitors of the electron transport. Production, isolation, physico-chemical and biological properties J Antibiot (Tokyo) 56 2003 827 831
19. H. Inoue, H. Kumagai, M. Osono, M. Matsufuji, T. Sameshima, N. Kawamura, T. Someno, M. Ishizuka, and T. Takeuchi ICM0201, a new inhibitor of osteoclastogenesis from Cunninghamella sp. F-1490. I. Taxonomy, fermentation, isolation and biological activities J Antibiot (Tokyo) 56 2003 209 213
20. T. Someno, H. Inoue, H. Kumagai, M. Ishizuka, and T. Takeuchi ICM0201, a new inhibitor of osteoclastogenesis from Cunninghamella sp. F-1490. II. Structure determination and synthesis J Antibiot (Tokyo) 56 2003 214 218
21. T. Zenkoh, Y. Ohtsu, S. Yoshimura, N. Shigematsu, S. Takase, and M. Hino The novel gluconeogenesis inhibitors FR225659 and FR225656 from Helicomyces sp. No. 19353. III. Structure determination J Antibiot (Tokyo) 56 2003 694 699
22. Y. Ohtsu, H. Sasamura, Y. Tsurumi, S. Yoshimura, S. Takase, M. Hashimoto, T. Shibata, M. Hino, and T. Fujii The novel gluconeogenesis inhibitors FR225659 and related compounds that originate from Helicomyces sp. No. 19353. I. Taxonomy, fermentation, isolation and physico-chemical properties J Antibiot (Tokyo) 56 2003 682 688
23. Y. Ohtsu, H. Sasamura, T. Shibata, H. Nakajima, M. Hino, and T. Fujii The novel gluconeogenesis inhibitors FR225659 and related compounds that originate from Helicomyces sp. No. 19353. II. Biological profiles J Antibiot (Tokyo) 56 2003 689 693
24. T.S. Bugni, V.S. Bernan, M. Greenstein, J.E. Janso, W.M. Maiese, C.L. Mayne, and C.M. Ireland Brocaenols A-C: novel polyketides from a marine derived Penicillium brocae J Org Chem 68 2003 2014 2017 The fungus Penicillium brocae was obtained from a tissue sample of a Fijian sponge (Zyzyya sp.). This is a newly described species and this is the first report of a chemical investigation of this species.
25. K. Minagawa, S. Kouzuki, J. Yoshimoto, Y. Kawamura, H. Tani, T. Iwata, Y. Terui, H. Nakai, S. Yagi, and N. Hattori Stachyflin and acetylstachyflin, novel anti-influenza A virus substances, produced by Stachybotrys sp. RF-7260. I. Isolation, structure elucidation and biological activities J Antibiot (Tokyo) 55 2002 155 164 Stachyflin represents a new class of anti-influenza virus agent, as it is structurally different from any known anti-influenza virus agent including amantadine and zanamivir and is particularly potent.
26. K. Minagawa, S. Kouzuki, and T. Kamigauchi Stachyflin and acetylstachyflin, novel anti-influenza A virus substances, produced by Stachybotrys sp. RF-7260. II. Synthesis and preliminary structure-activity relationships of stachyflin derivatives J Antibiot (Tokyo) 55 2002 165 171
27. H. Mori, Y. Urano, T. Kinoshita, S. Yoshimura, S. Takase, and M. Hino FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase III. Structure determination J Antibiot (Tokyo) 56 2003 181 185
28. H. Mori, F. Abe, S. Furukawa, S. Furukawa, F. Sakai, M. Hino, and T. Fujii FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC) II. Biological activities in animal models J Antibiot (Tokyo) 56 2003 80 86
29. •] provide an in-depth discussion of the step-wise discovery and characterization of biological activity of a fungal natural product.
30. Y. Masuoka, K. Shin-ya, K. Furihata, K. Nagai, K. Suzuki, Y. Hayakawa, and H. Seto Phoenistatin, a new gene expression-enhancing substance produced by Acremonium fusigerum J Antibiot (Tokyo) 54 2001 187 190
31. M. Kijima, M. Yoshida, K. Sugita, S. Horinouchi, and T. Beppu Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase J Biol Chem 268 1993 22429 22435
32. L. Huang, and Z. Xue Cephalotaxus alkaloids A. Brossi The Alkaloids vol 23 1984 Academic Press NY 157
33. M.A.J. Miah, T. Hudlicky, and J.W. Reed Cephalotaxus alkaloids G.A. Cordell The Alkaloids vol 51 1998 Academic Press NY 199
34. J. Kobayashi, M. Yoshinaga, N. Yoshida, M. Shiro, and H. Morita Cephalocyclidin A, a novel pentacyclic alkaloid from Cephalotaxus harringtonia var. nana J Org Chem 67 2002 2283 2286
35. J. Kobayashi, M. Sekiguchi, S. Shimamoto, H. Shigemori, H. Ishiyama, and A. Ohsaki Subincanadines A-C, novel quaternary indole alkaloids from Aspidosperma subincanum J Org Chem 67 2002 6449 6455
36. S. Yamamura, and Y. Hirata Daphniphyllum Alkaloids R.H.F. Manske The Alkaloids vol 15 1975 Academic Press NY 41
37. S. Yamamura Daphniphyllum alkaloids A. Brossi The Alkaloids vol 29 1986 Academic Press New York, NY 265
38. J. Kobayashi, H. Takatsu, Y. Shen, and H. Morita Daphniglaucins A and B, novel polycyclic quaternary alkaloids from Daphniphyllum glaucescens Org Lett 5 2003 1733 1736
39. A. Jossang, H. El Bitar, V.C. Pham, and T. Sévenet Daphcalycine, a novel heptacycle fused ring system alkaloid from Daphniphyllum calycinum J Org Chem 68 2003 300 304
40. J. Kobayashi, S. Ueno, and H. Morita Daphmanidin A, a novel hexacyclic alkaloid from Daphniphyllum teijsmanii J Org Chem 67 2002 6546 6549
41. S.P. Yang, and J.M. Yue Two novel alkaloids with a unique fused hexacyclic skeleton from Daphniphyllum subverticillatum J Org Chem 68 2003 7961 7966
42. Z.J. Zhan, S.P. Yang, and J.M. Yue Paxdaphnidines A and B, novel penta- and tetracyclic alkaloids from Daphniphyllum paxianum J Org Chem 69 2004 1726 1729 This paper and the study by Kobayashi et al. [40] describe several structurally complex alkaloids and their plausible biogenetic path.
43. R.W. Fitch, H.M. Garraffo, T.F. Spande, H.J. Yeh, and J.W. Daly Bioassay-guided isolation of epiquinamide, a novel quinolizidine alkaloid and nicotinic agonist from an Ecuadoran poison frog, Epipedobates tricolor J Nat Prod 66 2003 1345 1350 An interesting study of a natural product metabolite, specific for neuronal receptor subtypes. This paper provides insight into structural elucidation of a compound from a very limited resource.